Gastrointestinal Cancer News

The Oncology Nursing Society issued a position statement intended to clearly define the roles of oncology nurse navigators.

It is a disturbing fact that the costs of health care are spiraling upwards, and that an exemplar of this troubling trend is the domain of oncology treatment and research.

Skin and mucosal reactions to oral chemotherapeutic agents are common complications of cancer treatment and may severely impair patients’ quality of life.

The FDA approved trifluridine and tipiracil for the treatment of patients with metastatic colorectal cancer, according to a press release from its manufacturer.

Less than half of people opted to undergo a one-off flexible sigmoidoscopy after being invited as part of the English Bowel Scope Screening program, according to a recent study.

Drinking four or more cups of coffee on a daily basis may prevent colon cancer recurrence and death, according to prospective study results.

The U.S. Preventive Services Task Force has published a draft recommendation statement that indicates aspirin therapy is a viable approach in the prevention of colorectal cancer and cardiovascular disease.

Patients with inflammatory bowel disease undergoing regular surveillance colonoscopy had a low incidence of interval colorectal cancer, according to recent study data, prompting researchers to suggest up to 5 years between surveillance.

The FDA has granted fast track designation to Can-Fite BioPharma Ltd.’s CF102, a potential drug to treat hepatocellular carcinoma, according to a press release.

Neoadjuvant therapy encompasses all treatments that are administered before the primary cancer treatment, whereas adjuvant therapy describes regimens administered after the primary treatment.